NEW YORK (GenomeWeb News) – The biotechnology entrepreneur Alejandro Zaffaroni, who co-founded Affymetrix, has died at the age of 91, The New York Times has reported.

Originally from Uruguay, Zaffaroni helped to launch biotechnology and Silicon Valley companies beyond Affymetrix, including Alza, Syntex, Perlegen Sciences, Symyx Technologies, DNAX, and Maxygen. He also had a hand in bringing new technologies to market, including Affymetrix's biochips, as well as the birth control pill and the nicotine patch.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.